SPDR S&P Biotech ETF $XBI Stock: Sivik Global Healthcare LLC Boosts Stake

Sivik Global Healthcare LLC raised its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 20.0% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 180,000 shares of the exchange traded fund’s stock after purchasing an additional 30,000 shares during the period. SPDR S&P Biotech ETF accounts for approximately 17.5% of Sivik Global Healthcare LLC’s holdings, making the stock its biggest holding. Sivik Global Healthcare LLC’s holdings in SPDR S&P Biotech ETF were worth $28,382,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Fragasso Financial Advisors Inc raised its position in shares of SPDR S&P Biotech ETF by 4.8% during the 3rd quarter. Fragasso Financial Advisors Inc now owns 2,905 shares of the exchange traded fund’s stock worth $447,000 after purchasing an additional 133 shares during the period. Vertrix Wealth Management LLC boosted its position in SPDR S&P Biotech ETF by 5.0% during the 3rd quarter. Vertrix Wealth Management LLC now owns 1,503 shares of the exchange traded fund’s stock valued at $237,000 after purchasing an additional 71 shares during the period. Castleview Partners LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 61.9% during the third quarter. Castleview Partners LLC now owns 2,594 shares of the exchange traded fund’s stock valued at $409,000 after acquiring an additional 992 shares during the period. Wedmont Private Capital bought a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at about $684,000. Finally, Breakwater Capital Group lifted its position in SPDR S&P Biotech ETF by 2.5% in the 3rd quarter. Breakwater Capital Group now owns 20,157 shares of the exchange traded fund’s stock valued at $3,178,000 after purchasing an additional 501 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI traded down $3.93 during trading hours on Tuesday, hitting $147.47. The stock had a trading volume of 5,443,509 shares, compared to its average volume of 9,130,168. The stock’s fifty day simple moving average is $158.67 and its 200 day simple moving average is $146.36. The firm has a market capitalization of $9.88 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 1-year low of $103.43 and a 1-year high of $169.89.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.